PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 545.0
(-2.68%)
IDR 545.0
(-2.68%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2018.69 Billion IDR | -6.65% |
| 2022 | 2162.61 Billion IDR | -5.4% |
| 2021 | 2286.03 Billion IDR | 24.32% |
| 2020 | 1838.78 Billion IDR | 9.41% |
| 2019 | 1680.56 Billion IDR | 17.98% |
| 2018 | 1424.39 Billion IDR | 22.59% |
| 2017 | 1161.95 Billion IDR | 8.83% |
| 2016 | 1067.66 Billion IDR | 20.86% |
| 2015 | 883.36 Billion IDR | 5.22% |
| 2014 | 839.56 Billion IDR | -16.94% |
| 2013 | 1010.78 Billion IDR | 9.79% |
| 2012 | 920.64 Billion IDR | 4.89% |
| 2011 | 877.68 Billion IDR | 27.96% |
| 2010 | 685.93 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 383.85 Billion IDR | -18.65% |
| 2024 Q1 | 627.08 Billion IDR | -16.48% |
| 2024 Q2 | 466.91 Billion IDR | -25.54% |
| 2023 FY | 2018.69 Billion IDR | -6.65% |
| 2023 Q1 | 483.19 Billion IDR | -37.17% |
| 2023 Q2 | 394.35 Billion IDR | -18.39% |
| 2023 Q4 | 750.79 Billion IDR | 92.33% |
| 2023 Q3 | 390.36 Billion IDR | -1.01% |
| 2022 Q3 | 539.03 Billion IDR | 44.64% |
| 2022 Q1 | 481.82 Billion IDR | -33.46% |
| 2022 FY | 2162.61 Billion IDR | -5.4% |
| 2022 Q4 | 769.09 Billion IDR | 42.68% |
| 2022 Q2 | 372.66 Billion IDR | -22.66% |
| 2021 Q4 | 724.09 Billion IDR | 14.6% |
| 2021 Q1 | 447.93 Billion IDR | -27.93% |
| 2021 Q2 | 482.14 Billion IDR | 7.64% |
| 2021 Q3 | 631.85 Billion IDR | 31.05% |
| 2021 FY | 2286.03 Billion IDR | 24.32% |
| 2020 Q1 | 407.53 Billion IDR | -21.96% |
| 2020 Q3 | 435.89 Billion IDR | 16.62% |
| 2020 Q2 | 373.78 Billion IDR | -8.28% |
| 2020 FY | 1838.78 Billion IDR | 9.41% |
| 2020 Q4 | 621.57 Billion IDR | 42.6% |
| 2019 Q1 | 378.06 Billion IDR | -13.56% |
| 2019 Q4 | 522.17 Billion IDR | 30.47% |
| 2019 Q3 | 400.22 Billion IDR | 5.3% |
| 2019 Q2 | 380.09 Billion IDR | 0.54% |
| 2019 FY | 1680.56 Billion IDR | 17.98% |
| 2018 Q3 | 351.2 Billion IDR | 6.45% |
| 2018 FY | 1424.39 Billion IDR | 22.59% |
| 2018 Q4 | 437.35 Billion IDR | 24.53% |
| 2018 Q2 | 329.93 Billion IDR | 7.86% |
| 2018 Q1 | 305.89 Billion IDR | -5.54% |
| 2017 Q2 | 261.74 Billion IDR | 0.77% |
| 2017 Q4 | 323.82 Billion IDR | 2.26% |
| 2017 FY | 1161.95 Billion IDR | 8.83% |
| 2017 Q1 | 259.73 Billion IDR | -10.11% |
| 2017 Q3 | 316.65 Billion IDR | 20.98% |
| 2016 Q3 | 246.21 Billion IDR | -15.34% |
| 2016 Q4 | 288.93 Billion IDR | 17.35% |
| 2016 Q2 | 290.83 Billion IDR | 20.34% |
| 2016 FY | 1067.66 Billion IDR | 20.86% |
| 2016 Q1 | 241.67 Billion IDR | 0.52% |
| 2015 Q1 | 194.61 Billion IDR | -29.97% |
| 2015 Q3 | 188.89 Billion IDR | -27.19% |
| 2015 Q2 | 259.42 Billion IDR | 33.3% |
| 2015 FY | 883.36 Billion IDR | 5.22% |
| 2015 Q4 | 240.42 Billion IDR | 27.28% |
| 2014 Q1 | 196.11 Billion IDR | -41.15% |
| 2014 Q3 | 169.9 Billion IDR | -13.15% |
| 2014 Q2 | 195.63 Billion IDR | -0.24% |
| 2014 Q4 | 277.91 Billion IDR | 63.57% |
| 2014 FY | 839.56 Billion IDR | -16.94% |
| 2013 Q4 | 333.24 Billion IDR | 45.15% |
| 2013 FY | 1010.78 Billion IDR | 9.79% |
| 2013 Q2 | 267.68 Billion IDR | 48.49% |
| 2013 Q3 | 229.58 Billion IDR | -14.24% |
| 2013 Q1 | 180.27 Billion IDR | 0.0% |
| 2012 FY | 920.64 Billion IDR | 4.89% |
| 2011 FY | 877.68 Billion IDR | 27.96% |
| 2010 FY | 685.93 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 942.41 Billion IDR | -114.205% |
| PT Merck Tbk | 391.72 Billion IDR | -415.333% |
| PT Phapros, Tbk | 533.85 Billion IDR | -278.138% |
| PT Pyridam Farma Tbk | 282.01 Billion IDR | -615.815% |
| PT Tempo Scan Pacific Tbk | 4513.76 Billion IDR | 55.277% |